BHC — Bausch Health Companies Share News
0.000.00%
Last trade - 00:00- CA$4.64bn
- CA$32.51bn
- $10.27bn
Contact lens maker Bausch + Lomb confirms it is exploring sale (updated)
US Supreme Court declines to hear patent dispute over Bausch blockbuster diarrhea drug
Brief: Icahn Enterprises Discloses 4% Ownership Stake In Caesars Entertainment As Of Sept 30
Canada Stocks: TSX tumbles to three-week low; still posts monthly gain
Bausch Health Companies Inc expected to post earnings of $1.06 a share - Earnings Preview
Brief: Bausch Health Rejects Bondholders’ Debt Proposals, Explores Sale Of Vision Care Unit - WSJ
Canada Stocks: TSX down as energy stocks slide; inflation data boosts rate cut bets
Media: Bausch Health taps Jefferies to refinance debt, aid spinoff - Bloomberg News
Canada Stocks: Toronto stocks drop as miners and energy stocks slide
Canada Stocks: Toronto stocks drop as miners and energy stocks slide
Press Digest: Wall Street Journal - Aug 9
Brief: Bausch Plan To Spin Off Eye-Care Business Stuck In Creditor Standoff- WSJ
Bausch Health Companies Inc expected to post earnings of 88 cents a share - Earnings Preview
Bausch Health tumbles on unconfirmed report of bankruptcy
Bausch Health denies report of considering bankruptcy filing (updated)
Bausch Health denies report of bankruptcy filing
Brief: Bausch Health Companies On July 15 Appointed Jean-Jacques Charhon As Company's Executive Vice President And CFO, Effective As Of Aug 19
Bausch wins US appeal to block Alvogen generic of diarrhea drug
Brief: Bausch Can Block Alvogen From Copying Xifaxan Diarrhea Drug Until 2029-Us Appeals Court